Jian Zhang starts the presentation with prevalence data in China and the recommendation from Chinese Guidelines. Key messages of the presentation include:
- The unmet medical needs in patients with heart failure in China:
- Low prescription rates of guideline recommended medications
- Suboptimal heart rate control
- Data from China:
- SHIFT Chinese subgroup analysis
- POSITIVE study
- Other explorations (the combination of ivabradine in vulnerable and predischarge stages)
- The Chinese expert consensus recommends ivabradine in heart failure and other diseases:
- Early combination in patients with chronic HFrFE
- In vulnerable phase of heart failure
- AHF entered into pre-discharge stage
- Patients not tolerating or with contraindications to beta-blockers